1Matsumoto K, Yasui K, Yamashita N, et al. In vitro proliferation potential of AC133 positive cells in peripheral blood. Stem Cells, 2000, 18:196 - 203.
2Kalka C, Masuda H, Takashi T, et al. Vascular endothelial growth factor(165) gene transfer augments ciculating endothelial progenitor cells in human subjects. Cir Res, 2000,86:1198- 1202.
3Kalka C. MAC-133 postitive progenitor cells. Blood, 2000, 95:3106- 3112.
5Isner JM, Asahara T. Angiogenesie and vasculogenesis as therapeutic strategies for post natal neovascalarization. J Clin Invest, 1999, 103:1231- 1236.
6Kalka C, Masuda H, Takahashl T, et al. Transplantation of ex vivo expended endothelial progenitor cells for therapeutic neovascularization. Proc Natl Acad Sci USA, 2000,97:3422- 3427.
7Laham R.I, Post M, Senk FW, et al. Therapeutic angiogenesis using local perivaseular and pefieardial delivery. Curr Interv Cardiol Rep, 2000, 2:213 - 217.
8Schaper W, ho WD. Molecular mechanisms of coronary collateral vessel growth. Cire Res, 1996,79:911 - 919.
9Wu HM, Yuan Y, McCarthy M, et al. Acidic and basic FGFS dilate arerioles of skeletal muscle through a NO-depent mechanism. Am J Physiol,1996,271(3 pt 2) :H1087 - H1093.
10Ursula M, Gehling, Silleyman Ergtln, et al. In vitro differentiation of endothelial ceils from AC133-positive progenitor ceils. Blood, 2000, 95:3106- 3112.
